series-b
Stage
2
Investors
About
Sarcura developed a microfluidic on‑chip system to miniaturize and automate the manufacturing of cell therapies to enable scalable production. The company has been retired and is no longer active.
Explore Sarcura's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.